SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-09-003661
Filing Date
2009-05-07
Accepted
2009-05-07 07:46:52
Documents
3
Effectiveness Date
2009-05-07

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC b753838ke8vk.htm DEFA14A 16516
2 EX-99.1 PRESS RELEASE, DATED MAY 7, 2009, ANNOUNCING THE COMPANY'S FIRST QUARTER b753838kexv99w1.htm EX-99.1 67108
3 EX-99.2 PRESS RELEASE, DATED MAY 7, 2009, ANNOUNCING THE STRATEGIC TRANSACTION W b753838kexv99w2.htm EX-99.2 19784
  Complete submission text file 0000950135-09-003661.txt   104948
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50767 | Film No.: 09803479
SIC: 2834 Pharmaceutical Preparations